Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ)
CNY 8.34
(0.24%)
CNY 8.34
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 722.13 Million | 719.9 Million | 592.12 Million | 435.42 Million | 413.05 Million | 267.12 Million |
| Cost of Revenue | 501.78 Million | 486.45 Million | 413.27 Million | 283.26 Million | 290.2 Million | 188.93 Million |
| Gross Profit | 220.35 Million | 233.45 Million | 178.85 Million | 152.15 Million | 122.85 Million | 78.18 Million |
| Operating Expenses | 115.54 Million | 109.26 Million | 79.56 Million | 62.74 Million | 61.79 Million | 55.77 Million |
| Selling, General and Administrative Expenses | 32.13 Million | 23.25 Million | 23.44 Million | 17.65 Million | 18.44 Million | 24.79 Million |
| Research and Development Expenses | 63.15 Million | 60.91 Million | 39.02 Million | 35.3 Million | 36.33 Million | 25.35 Million |
| Other Expenses | 268.08 Thousand | 25.09 Million | 17.1 Million | 9.79 Million | 7.02 Million | 43.8 Thousand |
| Cost and Expenses | 617.32 Million | 595.71 Million | 492.83 Million | 346.01 Million | 352 Million | 244.71 Million |
| Operating Income | 112.23 Million | 106.33 Million | 88.34 Million | 78.24 Million | 51.68 Million | 26.28 Million |
| Interest Expense | 10.64 Million | 7.69 Million | 5.69 Million | 8.99 Million | 4.2 Million | 1625.00 |
| Income Tax Expense | 6.51 Million | 5.48 Million | 7.22 Million | 8 Million | 3.37 Million | 1.79 Million |
| Earnings before Tax | 112.5 Million | 106.14 Million | 88.34 Million | 78.05 Million | 51.68 Million | 26.32 Million |
| Net Income | 105.98 Million | 100.66 Million | 81.11 Million | 70.05 Million | 48.3 Million | 24.53 Million |
| Earnings Per Share Basic | 0.28 | 0.31 | 0.26 | 0.23 | 0.16 | 0.08 |
| Earnings Per Share Diluted | 0.28 | 0.29 | 0.24 | 0.23 | 0.16 | 0.08 |
| Weighted Average Shares Outstanding | 380.36 Million | 326.43 Million | 308.75 Million | 309.39 Million | 308.68 Million | 308.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 380.39 Million | 346.18 Million | 337.62 Million | 309.56 Million | 311.56 Million | 312.32 Million |
| Gross Margin | 0.31 | 0.32 | 0.30 | 0.35 | 0.30 | 0.29 |
| EBIT Margin | 0.27 | 0.26 | 0.26 | 0.32 | 0.25 | 0.20 |
| Profit Margin | 0.15 | 0.14 | 0.14 | 0.16 | 0.12 | 0.09 |
| EBITDA | 192.54 Million | 181.47 Million | 146.08 Million | 139.71 Million | 99.05 Million | 50.18 Million |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.15 | 0.18 | 0.13 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 187.88 Million | 175.59 Million | 205.59 Million | 162.47 Million | 722.13 Million | 177.9 Million |
| Cost of Revenue | 127.95 Million | 119.38 Million | 130.75 Million | 97.09 Million | 481.65 Million | 130.06 Million |
| Gross Profit | 59.92 Million | 56.21 Million | 74.84 Million | 65.38 Million | 240.48 Million | 47.84 Million |
| Operating Expenses | 33.82 Million | 28.9 Million | 35.06 Million | 31.29 Million | 117.85 Million | 24.22 Million |
| Selling, General and Administrative Expenses | 35.1 Million | 1.38 Million | 16.84 Million | -13.38 Million | - | 31.6 Million |
| Research and Development Expenses | 17.02 Million | 11.88 Million | 10.29 Million | 15.67 Million | - | 8.94 Million |
| Other Expenses | -18.29 Million | 196.94 Thousand | -7.92 Million | 327.35 Thousand | 268.08 Thousand | 1.5 Million |
| Cost and Expenses | 161.78 Million | 148.29 Million | 165.81 Million | 128.38 Million | 599.51 Million | 154.28 Million |
| Operating Income | 28.8 Million | 28.17 Million | 39.77 Million | 23.01 Million | 112.23 Million | 28.08 Million |
| Interest Expense | 4.01 Million | 5.09 Million | 4.06 Million | 3.72 Million | 9.89 Million | 1.65 Million |
| Income Tax Expense | 2.17 Million | 2.18 Million | 5.4 Million | -3.98 Million | 6.51 Million | 6.46 Million |
| Earnings before Tax | 28.35 Million | 28.17 Million | 48.96 Million | 23.34 Million | 112.5 Million | 28.08 Million |
| Net Income | 26.18 Million | 25.98 Million | 43.56 Million | 27.33 Million | 105.98 Million | 21.62 Million |
| Earnings Per Share Basic | 0.06 | 0.06 | 0.10 | 0.12 | - | 0.05 |
| Earnings Per Share Diluted | 0.06 | 0.06 | 0.10 | 0.12 | - | 0.05 |
| Weighted Average Shares Outstanding | 419.95 Million | 419.85 Million | 420.08 Million | 409 Million | 380.41 Million | 414.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 419.95 Million | 419.85 Million | 420.08 Million | 409 Million | 380.41 Million | 414.22 Million |
| Gross Margin | 0.32 | 0.32 | 0.36 | 0.40 | 0.33 | 0.27 |
| EBIT Margin | 0.17 | 0.21 | 0.31 | 0.27 | - | 0.17 |
| Profit Margin | 0.14 | 0.15 | 0.21 | 0.17 | 0.15 | 0.12 |
| EBITDA | 32.37 Million | 37.43 Million | 63.47 Million | 44.07 Million | - | 30.19 Million |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.19 | 0.14 | 0.16 | 0.16 |
4538
CDBDF
UPPR
MSLA
MPZZF
000760